Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study
Open Access
- 22 July 2020
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-8
Abstract
Background: The risk of viral hepatitis among healthcare students (HCSs) is greater than that among the general population. Therefore, this study was conducted to investigate the seroprevalence of the hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among first-year HCSs at a university in Turkey and as a secondary objective, to determine the factors associated with HAV and HBV seropositivity. Methods: This cross-sectional study was performed in first-year HCSs in Izmir, western Turkey. Data were collected using a self-administered questionnaire including items on sociodemographic characteristics, medical history, and hygiene. A total of 650 HCSs were tested for the HAV, HBV and HCV markers. Categorical variables were compared using the chi-square test. The association between independent variables and anti-HAV seropositivity and anti-HBs seropositivity was assessed by multinomial logistic regression analysis. Results: The overall frequency of total anti-HAV seropositivity was 34.9%. HBsAg, total anti-HBc and anti-HBs seropositivity were found in 0.3, 1.2 and 93.7% of samples, respectively. All of the HCSs were negative for anti-HCV. Total anti-HAV seropositivity was found to be 1.73 times higher in those ≥21 years old, and it was 1.61 times higher in those who perceived their economic status to be average and 2.75 times higher in those who perceived their economic status to be low. Total anti-HAV seropositivity was found to be 4.37 times higher in those who lived in provinces with intermediate human development index levels. Total anti-HBs seropositivity was found to be 2.48 times higher in those ≤20 years old, and it was 2.13 times higher in those who perceived their economic status to be average. Conclusions: Approximately two out of three HCSs were susceptible to HAV infection. Since HCSs are at high risk for HAV infection, they should be vaccinated before medical clerkships begin. Our results indicate that there is a high prevalence of anti-HBs seropositivity among HCSs. This result may be largely attributed to the implementation of a successful vaccination program in Turkey since 1998.Keywords
This publication has 27 references indexed in Scilit:
- Hepatitis A Seroprevalence and Contributing Factors in the Sixth Year Medical Faculty StudentsTAF Preventive Medicine Bulletin, 2013
- Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical studentsBMC Public Health, 2012
- Serologic Testing for Protection against Hepatitis B Virus Infection among Students at a Health Sciences University in the United StatesInfection Control & Hospital Epidemiology, 2012
- Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic reviewBMC Infectious Diseases, 2011
- Hepatitis A antibody seroprevalence among medical school studentsAmerican Journal of Infection Control, 2011
- Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern BrazilCadernos de Saude Publica, 2011
- Hepatitis A virus seroprevalence by age and world region, 1990 and 2005Vaccine, 2010
- Hepatitis B and C seropositivity among nursing students at a Turkish universityInternational Nursing Review, 2010
- Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: An implication for boostingVaccine, 2007
- Hepatitis A and B seropositivity among medical studentsHealth Policy, 2005